Covid-19: Oxford vaccine shows ‘promising’ immune response in the elderly

Image caption,

Elisa Granato is one of the volunteers who was given the Oxford vaccine

The Oxford coronavirus vaccine shows a strong immune response in adults aged 60 and 70, raising hopes that it can protect the age groups most at risk from the virus.

The researchers say the Lancet phase two results, based on 560 healthy adult volunteers, are “encouraging.”

They are also checking whether the vaccine is preventing people from developing Covid-19 in larger phase three trials.

The first results of this crucial step are expected in the coming weeks.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.